BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammer HF. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes. Dig Dis. 2010;28:339-343. [PMID: 20814209 DOI: 10.1159/000319411] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, Aggarwal M, Garg R, Stevens T, Chahal P. Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches. Ann Med 2022;54:1776-86. [PMID: 35786076 DOI: 10.1080/07853890.2022.2090601] [Reference Citation Analysis]
2 Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, Kanno A, Kida M, Sakagami J, Sata N, Takeyama Y, Tahara J, Hirota M, Fujimori N, Masamune A, Mochida S, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol 2022. [PMID: 35994093 DOI: 10.1007/s00535-022-01911-6] [Reference Citation Analysis]
3 Maehira H, Iida H, Mori H, Nitta N, Maekawa T, Tokuda A, Takebayashi K, Kaida S, Miyake T, Tani M. Aggressive Intervention of Pancrelipase After Pancreatectomy Prevents Deterioration of Postoperative Nutritional Status. Pancreas 2022;51:394-8. [PMID: 35695803 DOI: 10.1097/MPA.0000000000002035] [Reference Citation Analysis]
4 Diéguez-Castillo C, Jiménez-Luna C, Martín-Ruiz JL, Martínez-Galán J, Prados J, Torres C, González-Ramírez AR, Caba O. Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis. J Clin Med 2020;9:E2014. [PMID: 32604940 DOI: 10.3390/jcm9062014] [Reference Citation Analysis]
5 Dunbar RL, Gaudet D, Davidson M, Rensfeldt M, Yang H, Nilsson C, Kvarnström M, Oscarsson J. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids Health Dis 2020;19:117. [PMID: 32473640 DOI: 10.1186/s12944-020-01295-7] [Reference Citation Analysis]
6 Radlinger B, Ramoser G, Kaser S. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes. Curr Diab Rep 2020;20:18. [PMID: 32239341 DOI: 10.1007/s11892-020-01304-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Prasanna T, McNeil CM, Nielsen T, Parkin D. Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy. Immunotherapy 2018;10:171-5. [PMID: 29370723 DOI: 10.2217/imt-2017-0126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Yamamoto A, Ito K, Yasokawa K, Kanki A, Tanimoto D, Hayashida M, Tamada T. Symptoms that are associated with decreased pancreatic enzyme flow: MRCP assessment. J Magn Reson Imaging 2019;50:417-23. [PMID: 30637845 DOI: 10.1002/jmri.26619] [Reference Citation Analysis]
9 Leerhøy B, Shabanzadeh DM, Nordholm-Carstensen A, Novovic S, Hansen MB, Jørgensen LN. Pancreatic function following post-endoscopic retrograde cholangiopancreatography pancreatitis: A controlled cohort study with long-term follow-up. United European Gastroenterol J 2018;6:586-94. [PMID: 29881614 DOI: 10.1177/2050640617742498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018;72. [PMID: 29405509 DOI: 10.1111/ijcp.13066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
11 Marra-Lopez Valenciano C, Bolado Concejo F, Marín Serrano E, Millastre Bocos J, Martínez-Moneo E, Pérez Rodríguez E, Francisco González M, Del Pozo-García A, Hernández Martín A, Labrador Barba E, Orera Peña ML, de-Madaria E. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study. Gastroenterol Hepatol 2018;41:77-86. [PMID: 28935122 DOI: 10.1016/j.gastrohep.2017.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Schulze A, Breite D, Kim Y, Schmidt M, Thomas I, Went M, Fischer K, Prager A. Bio-Inspired Polymer Membrane Surface Cleaning. Polymers (Basel) 2017;9:E97. [PMID: 30970776 DOI: 10.3390/polym9030097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas 2016;45:679-86. [PMID: 26495784 DOI: 10.1097/MPA.0000000000000514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
14 Tseng DS, Molenaar IQ, Besselink MG, van Eijck CH, Borel Rinkes IH, van Santvoort HC. Pancreatic Exocrine Insufficiency in Patients with Pancreatic or Periampullary Cancer: A Systematic Review. Pancreas. 2016;45:325-330. [PMID: 26495777 DOI: 10.1097/mpa.0000000000000473] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
15 Heubi JE, Schaeffer D, Ahrens RC, Sollo N, Strausbaugh S, Graff G, Jain R, Witte S, Forssmann K. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. J Pediatr. 2016;176:156-161.e1. [PMID: 27297209 DOI: 10.1016/j.jpeds.2016.05.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
16 Aronson JK. Defining 'nutraceuticals': neither nutritious nor pharmaceutical. Br J Clin Pharmacol. 2017;83:8-19. [PMID: 26991455 DOI: 10.1111/bcp.12935] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
17 Lévy P, Domínguez-Muñoz E, Imrie C, Löhr M, Maisonneuve P. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterol J 2014;2:345-54. [PMID: 25360312 DOI: 10.1177/2050640614548208] [Cited by in Crossref: 133] [Cited by in F6Publishing: 97] [Article Influence: 16.6] [Reference Citation Analysis]
18 Afghani E, Sinha A, Singh VK. An overview of the diagnosis and management of nutrition in chronic pancreatitis. Nutr Clin Pract 2014;29:295-311. [PMID: 24743046 DOI: 10.1177/0884533614529996] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
19 Hammer HF. An update on pancreatic pathophysiology (do we have to rewrite pancreatic pathophysiology?). Wien Med Wochenschr 2014;164:57-62. [PMID: 24468827 DOI: 10.1007/s10354-013-0260-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
20 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
21 Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [PMID: 22936895 DOI: 10.2147/ce.s26705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
22 Olesen AE, Olofsen E, Olesen SS, Staahl C, Andresen T, Dahan A, Drewes AM. The absorption profile of pregabalin in chronic pancreatitis. Basic Clin Pharmacol Toxicol. 2012;111:385-390. [PMID: 22716224 DOI: 10.1111/j.1742-7843.2012.00914.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
23 Muneyuki T, Nakajima K, Aoki A, Yoshida M, Fuchigami H, Munakata H, Ishikawa SE, Sugawara H, Kawakami M, Momomura S, Kakei M. Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults. Cardiovasc Diabetol 2012;11:80. [PMID: 22748134 DOI: 10.1186/1475-2840-11-80] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]